, Tracking Stock Market Picks
Enter Symbol:
Arena Pharmaceuticals, Inc. (ARNA) [hlAlert]

down 68.82 %

Arena Pharmaceuticals, Inc. (ARNA) rated Buy

Posted on: Tuesday,  Dec 18, 2007  2:25 PM ET by Morgan Joseph

Morgan Joseph rated Buy Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) on 12/18/2007, when the stock price was $8.50. Since
then, Arena Pharmaceuticals, Inc. has lost 68.82% as of 10/08/2015's recent price of $2.65.
If you would have followed this Morgan Joseph's recommendation on ARNA, you would have lost 68.82% of your investment in 2851 days.

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase three clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/18/2007 2:25 PM Buy
8.50 18.00
as of 8/27/2015
1 Week down  -24.71 %
1 Month down  -40.84 %
3 Months down  -37.64 %
1 YTD down  -54.70 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy